Number of People with Type 1 Diabetes Forecasted to Double by 2040
Drug Topics
SEPTEMBER 22, 2022
Modeling indicates a significant increase in patients with type 1 diabetes over the next several years.
Thu.Sep 22, 2022
448 
The Impact of a Pharmacist on Epilepsy
Pharmacy Times
SEPTEMBER 22, 2022
Pharmacists are an essential part of improving care for patients with epilepsy.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Advocating for Increased Access to Medication for Treating Opioid Use Disorder
Drug Topics
SEPTEMBER 22, 2022
The National Commission on Correctional Health Care and 166 other national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.
First patient dosed with HIV gene therapy
European Pharmaceutical Review
SEPTEMBER 22, 2022
A breakthrough gene-editing therapy for human immunodeficiency virus type 1 (HIV) infection has entered first-in-human testing in what is being called “a major milestone in the search for a cure for HIV/AIDS”. EBT-101, a CRISPR-Cas9 gene editing system delivered by adenovirus-associated virus vector serotype 9 (AAV9) has been administered to the first individual in a Phase I/II trial designed to establish its safety and efficacy.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Nonopioid Pain Reliever Prescriptions on the Rise, as Opioid Prescriptions Decline
Drug Topics
SEPTEMBER 22, 2022
Study finds growth in three years after CDC guideline for primary care clinicians.
Monitoring Patients with C. difficile Infection (CDI) and rCDI
Pharmacy Times
SEPTEMBER 22, 2022
Dr Teena Chopra shares her approach to monitoring patients with C difficile infection (CDI).
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
NIH launches the next stage of its ‘human genome project’ for the brain
STAT
SEPTEMBER 22, 2022
The National Institutes of Health on Thursday announced more than $600 million in fresh funding for an expansive and ongoing push to unravel the mysteries of the human brain, bankrolling efforts to create a detailed map of the whole brain, and devise new ways to target therapeutics and other molecules to specific brain cell populations. Scientists across the country are involved, from teams at the Salk Institute to Duke University to the Broad Institute of MIT and Harvard, among other places.
Acupuncture May Reduce Anxiety in Patients With Parkinson’s Disease
Pharmacy Times
SEPTEMBER 22, 2022
Research suggests that acupuncture may be able to clinically reduce symptoms of anxiety in this patient population.
Using RWE in rare disease drug development: effective innovations with historical controls
European Pharmaceutical Review
SEPTEMBER 22, 2022
Rare disease drug development poses unique challenges that can be overcome by using real-world evidence (RWE). Small populations, paediatric patients, and the desire from patients and their caregivers to receive active therapy can make the conduct of randomised trials with placebo control untenable. As an alternative, regulatory agencies have allowed the use of RWE to estimate a historical control (HC) compared to patients enrolled in an uncontrolled study.
FDA Grants Priority Review to Tucatinib With Trastuzumab to Treat HER2 Colorectal Cancer
Pharmacy Times
SEPTEMBER 22, 2022
The FDA accepted a supplemental New Drug Application for tucatinib to treat HER2 colorectal cancer, which could significantly improve outcomes for these patients.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
CVS Health reports progress against goal to reduce suicide attempts among Aetna members
Drug Store News
SEPTEMBER 22, 2022
CVS Health has seen a 15.7% reduction in suicide attempts among Aetna members through March 2022 compared to 2019 baselines.
Bayer’s venture arm ramps up, seeking to invest $1.3 billion
STAT
SEPTEMBER 22, 2022
Over the last six years, a venture capital team run out of pharmaceutical giant Bayer invested roughly $1.5 billion into small biotech startups. Now, it’s ramping up. The firm plans to invest a nearly identical pot of money — this time, $1.3 billion — in half the time.
Target kicks off holiday shopping season in October
Drug Store News
SEPTEMBER 22, 2022
The retailer will run its annual holiday Deal Days omnichannel sale from Oct. 6 to 8.
STAT+: Envision Healthcare teeters on the brink of bankruptcy
STAT
SEPTEMBER 22, 2022
Envision Healthcare, the large chain of outpatient surgery centers and physician staffing services for hospitals, is on the cusp of bankruptcy and likely will run out of cash by the end of next year. Moody’s Investors Service on Wednesday downgraded Envision’s debt to its lowest possible junk-level rating, one that indicates the debt is “typically in default, with little prospect for recovery of principal and interest.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
FDA Approves Selpercatinib for Advanced, Metastatic Solid Tumors With RET Gene Fusion
Pharmacy Times
SEPTEMBER 22, 2022
Selpercatinib produced clinically meaningful and durable responses across a variety of tumor types in patients with RET-driven cancers.
GSK requires supplier sustainability compliance from 2023
European Pharmaceutical Review
SEPTEMBER 22, 2022
At Climate Week NYC GSK presented its new Sustainable Procurement Programme, announcing a fresh agenda, outlining how they will support their suppliers to succeed in their bold environmental objectives: have a net zero climate impact and a net positive impact on nature. This is an important move, as many GSK suppliers do not have easy geographical access to green infrastructure or green financing.
Serotonin Syndrome Versus Neuroleptic Malignant Syndrome
Med Ed 101
SEPTEMBER 22, 2022
Serotonin syndrome and neuroleptic malignant syndrome (NMS) are two commonly taught drug-induced syndromes but are rarely encountered in practice. I wanted to put together some important differences between these two syndromes because many of the symptoms overlap. Some of those classic overlapping symptoms include hyperthermia, hypertension, and tachycardia.
Opinion: Public health agencies: learn from NASA about regaining the public’s trust
STAT
SEPTEMBER 22, 2022
The amazing images of the Cartwheel Galaxy captured by the James Webb Space Telescope this summer, and before them the spectacular images from the Hubble telescope, have amazed and inspired many people worldwide, who now look to NASA as a trusted federal agency. It hasn’t always enjoyed such strong support. After the Challenger disaster , in which the space shuttle with seven crew members aboard exploded after liftoff, NASA was beset by questions about its decision-making and faced a sign
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Prescribing Controlled Substances Goes Electronic
Pharmacy Times
SEPTEMBER 22, 2022
Eliminating paper prescriptions allows for greater legibility, security, trackability for pharmacists, providers.
Can blockchain solve health care’s security problems? The financial industry offers a valuable case study
STAT
SEPTEMBER 22, 2022
This story has been excerpted from the STAT Report , “STAT’s guide to blockchain in health care.” N ot long ago, blockchain technology captured the imagination — and the wallets — of financial services firms that sought a “first-mover” advantage by integrating it into their outdated management systems.
NICE says yes to BeiGene’s Brukinsa after Scottish nay
pharmaphorum
SEPTEMBER 22, 2022
BeiGene’s BTK inhibitor Brukinsa (zanubrutinib) has become the first drug in the class to be recommended for routine NHS use in England and Wales to treat Waldenström macroglobulinaemia (WM) – a rare form of non-Hodgkin lymphoma (NHL). The final appraisal document from health technology assessment (HTA) agency NICE says that Brukinsa can be used to treat WM in adults who have had at least one prior treatment, and only if bendamustine plus rituximab therapy is also suitable.
Upsher-Smith expands partnership with Appco
Drug Store News
SEPTEMBER 22, 2022
The collaboration is part of Upsher-Smith’s effort to grow its portfolio of products through strategic partnerships and product acquisitions.
STAT+: Pharmalittle: Biogen ALS drug trial yields mixed signals; Novartis makes U.S. growth its top priority
STAT
SEPTEMBER 22, 2022
Hello, everyone, and how are you today? A dank cloudy cover greeted us this morning, but we are ignoring the gloom by keeping busy. After all, there is much to be done. There are deadlines to meet, a variety of reading material to digest, and calls to make. We trust you can relate. So please join us as we fortify ourselves with more cups of stimulation — we are back to blueberry cobbler — and get started.
Publix accepts donations to support Puerto Rico disaster relief efforts
Drug Store News
SEPTEMBER 22, 2022
The campaign will run in stores in Florida within the company’s Jacksonville, Lakeland and Miami divisions.
FDA and NIH partner to understand ALS
European Pharmaceutical Review
SEPTEMBER 22, 2022
The US Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have launched the Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership designed to further understand neurodegenerative diseases and advance treatment development for amyotrophic lateral sclerosis (ALS) and similar rare neurodegenerative conditions.
AllianceRx Walgreens Pharmacy reduces annual patient prescription costs by $6M
Drug Store News
SEPTEMBER 22, 2022
Clinical audit programs prevent waste, improve adherence, reduce spend and provide outcomes data, the company said.
Type 2 Diabetes Treatment Semaglutide May Also Treat Obesity
Pharmacy Times
SEPTEMBER 22, 2022
Semaglutide is a traditional type 2 diabetes treatment that may help obese individuals lose weight, especially if given at a higher dose.
Pepsi delivers s’mores-inspired flavors with mix-and-match beverages
Drug Store News
SEPTEMBER 22, 2022
The s’mores collection features three distinct flavors all packed into individual cans to encourage mixing and matching for the right flavor combination.
Case Studies: September 2022
Pharmacy Times
SEPTEMBER 22, 2022
How would you respond to these patient questions?
CHPA announces Regulatory & Scientific Affairs award recipients
Drug Store News
SEPTEMBER 22, 2022
The award honors individuals maintaining a career of exceptional service and contributions within the consumer healthcare products industry.
NIH Explores New Field of Liberation Data Science in All of Us Research Program
Pharmacy Times
SEPTEMBER 22, 2022
The All of Us Research Program looks to enroll more than 1 million US individuals in the next 10 years to enable public access to medical data for research purposes.
Tweezerman, Tom Bachik perfect manicures with Ultimate Nail Care Set
Drug Store News
SEPTEMBER 22, 2022
The Tweezerman x Tom Bachik Ultimate Nail Care Set features essential tools for creating the ideal manicure and pedicure.
Hypercholesterolemia Counseling Improves Adherence
Pharmacy Times
SEPTEMBER 22, 2022
Pharmacist education also helps prevent adverse reactions, maximizes outcomes for the symptomless disease.
Let's personalize your content